Literature DB >> 12603815

Molecular changes in fetal Down syndrome brain.

Ephrem Engidawork1, Gert Lubec.   

Abstract

Trisomy of human chromosome 21 is a major cause of mental retardation and other phenotypic abnormalities collectively known as Down syndrome. Down syndrome is associated with developmental failure followed by processes of neurodegeneration that are known to supervene later in life. Despite a widespread interest in Down syndrome, the cause of developmental failure is unclear. The brain of a child with Down syndrome develops differently from that of a normal one, although characteristic morphological differences have not been noted in prenatal life. On the other hand, a review of the existing literature indicates that there are a series of biochemical alterations occurring in fetal Down syndrome brain that could serve as substrate for morphological changes. We propose that these biochemical alterations represent and/or precede morphological changes. This review attempts to dissect these molecular changes and to explain how they may lead to mental retardation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603815     DOI: 10.1046/j.1471-4159.2003.01614.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro.

Authors:  Bruno H S Araujo; Carolini Kaid; Janaina S De Souza; Sérgio Gomes da Silva; Ernesto Goulart; Luiz C J Caires; Camila M Musso; Laila B Torres; Adriano Ferrasa; Roberto Herai; Mayana Zatz; Oswaldo K Okamoto; Esper A Cavalheiro
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

3.  Structural brain alterations of Down's syndrome in early childhood evaluation by DTI and volumetric analyses.

Authors:  Hediye Pınar Gunbey; Meltem Ceyhan Bilgici; Kerim Aslan; Arzu Ceylan Has; Methiye Gonul Ogur; Aslıhan Alhan; Lutfi Incesu
Journal:  Eur Radiol       Date:  2016-10-31       Impact factor: 5.315

Review 4.  The role of DYRK1A in neurodegenerative diseases.

Authors:  Jerzy Wegiel; Cheng-Xin Gong; Yu-Wen Hwang
Journal:  FEBS J       Date:  2010-12-13       Impact factor: 5.542

Review 5.  Neurological phenotypes for Down syndrome across the life span.

Authors:  Ira T Lott
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

6.  Segmentation of the foveal and parafoveal retinal architecture using handheld spectral-domain optical coherence tomography in children with Down syndrome.

Authors:  Catherine M Hill; Helena Lee; Rory Nicholson; Daniel Osborne; Lisa Fairhead; Leonora Beed
Journal:  Eye (Lond)       Date:  2022-01-10       Impact factor: 4.456

7.  [Urological manifestations of Down syndrome: significance and long-term complications -- our own patient cohort with an overview].

Authors:  A K Ebert; S Brookman-Amissah; W H Rösch
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

8.  Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.

Authors:  Karol Charkiewicz; Agnieszka Blachnio-Zabielska; Monika Zbucka-Kretowska; Slawomir Wolczynski; Piotr Laudanski
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

Review 9.  Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.

Authors:  Sara Anna Bonini; Andrea Mastinu; Giulia Ferrari-Toninelli; Maurizio Memo
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

Review 10.  Intellectual disability: dendritic anomalies and emerging genetic perspectives.

Authors:  Tam T Quach; Harrison J Stratton; Rajesh Khanna; Pappachan E Kolattukudy; Jérome Honnorat; Kathrin Meyer; Anne-Marie Duchemin
Journal:  Acta Neuropathol       Date:  2020-11-23       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.